An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
2018 ◽
Vol 36
(15_suppl)
◽
pp. 9095-9095
◽
Keyword(s):
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. e24062-e24062
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 38
(15_suppl)
◽
pp. e21506-e21506
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):